高级检索
当前位置: 首页 > 详情页

Effects of Feiwei granules in the treatment of idiopathic pulmonary fibrosis: a randomized and placebo-controlled trial

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ CSCD-C

单位: [1]Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China [2]Department of Respiratory Medicine, the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300150, China [3]Respiratory Pyrexia Department, Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100078, China [4]Department of Respiratory Medicine, Xiyuan Hospital of China Academy of Traditional Chinese Medicine, Beijing 100091, China [5]Department of Respiratory Medicine, Qingdao Hiser Medical Group, Shandong 266033, China [6]Department of Respiratory Disease of Traditional Chinese Medicine, China-Japan Friendship Hospital, Beijing 100029, China
出处:
ISSN:

关键词: Idiopathic pulmonary fibrosis Dyspnea Surveys and questionnaires 6-min walking test Feiwei granules Jinshuibao capsules Randomized controlled trial

摘要:
OBJECTIVE: To document the therapeutic effects of Feiwei granules (FGs) for idiopathic pulmonary fibrosis (IPF). METHODS: One hundred cases with IPF were randomized into the treatment group (80) and control group (20). Both groups were given basic treatment with prednisone. The treatment group was given FGs, and the control group was given Jinshuibao capsules (JCs). Treatment lasted for 6 months. The Medical Research Council Dyspnea Scale (MRCDS), the Saint George's Hospital Respiratory Questionnaire (SGHRQ), pulmonary function, the Traditional Chinese Medicine Syndrgme Score (TC-MSS), 6-min walking test (6MWT) and blood gas analyses were recorded before the study as well as 3 months and 6 months after treatment. RESULTS: FGs showed greater efficacy than the control in certain parameters between before the study and 6 months, and between 3 months and 6 months, in the MRCDS, some indicators in the SGHRQ, and the TCMSS. There were no significant differences between the treatment group and control group in the remainder of the indices evaluated. In the treatment group, there were significant differences in before and after treatment in the MRCDS, SGHRQ, TCMSS and 6MWT. CONCLUSION: FGs were similar to JCs for IPF treatment. (C) 2016 JTCM. All rights reserved.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 4 区 医学
小类 | 4 区 全科医学与补充医学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 全科医学与补充医学
JCR分区:
出版当年[2014]版:
Q4 INTEGRATIVE & COMPLEMENTARY MEDICINE
最新[2023]版:
Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2014版] 出版当年五年平均[2010-2014] 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者单位: [1]Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China
通讯作者:
通讯机构: [6]Department of Respiratory Disease of Traditional Chinese Medicine, China-Japan Friendship Hospital, Beijing 100029, China [*1]Department of Respiratory Disease of Traditional Chinese Medicine, China- Japan Friendship Hospital, Beijing 100029, China. [*2]Department of Respiratory Disease of Traditional Chinese Medicine, China-Japan Friendship Hospital, Beijing 100029, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)